Wen, MD, Director of the Center for Neuro-Oncology at Dana-Farber Cancer Institute. Details for the RANO 2.0 presentation as well as other pipeline presentations at SNO are as follows: Title: Response ...

Nanoscope Therapeutics, Inc., a late-stage clinical biotechnology company developing gene therapies for inherited retinal diseases and age-related macular degeneration (AMD), today announced ...

Tempus AI, Inc. (NASDAQ: TEM), a technology company leading the adoption of AI to advance precision medicine and patient care, today announced nine abstracts were accepted for presentation at the ...

AGOURA HILLS, Calif., Nov. 06, 2024 (GLOBE NEWSWIRE) -- Oncotelic Therapeutics, Inc (OTCQB:OTLC) announced today its presentation at SITC 2024. Dr. Cynthia Lee, VP of R&D will be presenting Sapu Bio ...

Two poster presentations to feature novel data from the Phase 1/2 SIDNEY trial of EO2463 in indolent Non-Hodgkin Lymphoma (iNHL), highlighting initial data from Cohort 2 as monoth ...

Two poster presentations to feature novel data from the Phase 1/2 SIDNEY trial of EO2463 in indolent Non-Hodgkin Lymphoma (iNHL), highlighting initial data from Cohort 2 as monotherapy in a ...

STATEN ISLAND, N.Y. – Staten Island University Hospital (SIUH) has appointed Dr. Thomas Bradley director of hematology and ...

Deborah Kelly, who specializes in cancer research, is still listed online as the director ... submitting publications, or making presentations on behalf of the Pennsylvania State University,” the ...

JANESVILLE — During breast cancer awareness month, Mercyhealth hosted a free presentation and dinner on Wednesday evening that informed women and men in the Rock county community about ...

The presentations include new data on its preclinical biomarker-based approach for KT-253, its MDM2 degrader. “We have built industry leading knowledge and capabilities that we are leveraging to ...

today announced upcoming scientific presentations for NXP900 at the 2024 AACR-NCI-EORTC on Molecular Targets and Cancer Therapeutics (October 23-25, 2024, Barcelona, Spain). Certain statements in ...